Abris Capital Partners sold its majority stake in Chemes to Innova Capital, signaling a strategic consolidation in the Polish label manufacturing sector.
Information on the Target
On April 17, 2019, Abris Capital Partners divested its majority stake in Chemes, a prominent player in the label manufacturing sector, to Innova Capital. Over the past 3.5 years of ownership, Abris has significantly developed the company through substantial investments in production infrastructure and technology. These enhancements enabled Chemes to penetrate unexplored markets and expand its customer base, reinforcing its status in the industry.
Since Abris CEE Mid-Market Fund II acquired a majority stake in Chemes in 2015, there has been a strategic focus on growth and innovation. Under the leadership of Maciej Szperliński, the company introduced new product lines, such as laminated tubes, and undertook significant improvements in organizational effectiveness and management structure. These initiatives have led to a marked increase in sales and operational proficiency, establishing Chemes as a recognized name in the label sector. The company now serves both publicly traded and medium-sized FMCG clients across Europe, spanning sectors like cosmetics, personal hygiene, food production, and logistics.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Poland
The label manufacturing industry in Poland has experienced robust growth in recent years, driven by increased demand across various sectors, including food and beverage, personal care, and pharmaceuticals. The rise of e-commerce and changes in c
Similar Deals
One Equity Partners → McNICHOLS CO.
2025
Heidelberg Materials → Midway Concrete
2025
Innova Capital
invested in
Chemes
in 2019
in a Buy & Build / Roll-Up deal